{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T17:40:57Z","timestamp":1792172457919,"version":"4.4.0"},"reference-count":209,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T00:00:00Z","timestamp":1759363200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"DOI":"10.13039\/100019475","name":"Sidra Medicine","doi-asserted-by":"publisher","award":["SDR400215"],"award-info":[{"award-number":["SDR400215"]}],"id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019475","name":"Sidra Medicine","doi-asserted-by":"publisher","award":["SDR400217"],"award-info":[{"award-number":["SDR400217"]}],"id":[{"id":"10.13039\/100019475","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Cell Mol Biol Lett"],"DOI":"10.1186\/s11658-025-00786-8","type":"journal-article","created":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T12:21:29Z","timestamp":1759407689000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Hypoimmune stem cells and islets: hype or a true breakthrough in diabetes treatment?"],"prefix":"10.1186","volume":"30","author":[{"given":"Karim E.","family":"Shalaby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7764-6772","authenticated-orcid":false,"given":"Essam M.","family":"Abdelalim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,10,2]]},"reference":[{"issue":"Suppl 1","key":"786_CR1","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.2337\/dc21-S002","volume":"44","author":"American Diabetes A","year":"2021","unstructured":"American Diabetes A. 2. Classification and diagnosis of diabetes: standards of medical care in diabetes-2021. Diabetes Care. 2021;44(Suppl 1):S15\u201333.","journal-title":"Diabetes Care"},{"key":"786_CR2","doi-asserted-by":"crossref","unstructured":"Sun H, Saeedi P, Karuranga S, Pinkepank M, Ogurtsova K, Duncan BB, et\u00a0al. Erratum to \u201cIDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045\u201d [Diabetes Res. Clin. Pract. 183 (2022) 109119]. Diabetes Res Clin Pract. 2023; 204:110945.","DOI":"10.1016\/j.diabres.2023.110945"},{"issue":"10","key":"786_CR3","doi-asserted-by":"publisher","first-page":"1052","DOI":"10.1001\/jama.2015.9536","volume":"314","author":"DM Nathan","year":"2015","unstructured":"Nathan DM. Diabetes: advances in diagnosis and treatment. JAMA. 2015;314(10):1052\u201362.","journal-title":"JAMA"},{"issue":"10085","key":"786_CR4","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1016\/S0140-6736(17)30058-2","volume":"389","author":"S Chatterjee","year":"2017","unstructured":"Chatterjee S, Khunti K, Davies MJ. Type 2 diabetes. Lancet. 2017;389(10085):2239\u201351.","journal-title":"Lancet"},{"issue":"6","key":"786_CR5","doi-asserted-by":"publisher","first-page":"2459","DOI":"10.1007\/s00018-020-03710-9","volume":"78","author":"EM Abdelalim","year":"2021","unstructured":"Abdelalim EM. Modeling different types of diabetes using human pluripotent stem cells. Cell Mol Life Sci. 2021;78(6):2459\u201383.","journal-title":"Cell Mol Life Sci"},{"issue":"6","key":"786_CR6","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1016\/j.stem.2018.05.016","volume":"22","author":"JB Sneddon","year":"2018","unstructured":"Sneddon JB, Tang Q, Stock P, Bluestone JA, Roy S, Desai T, et\u00a0al. Stem cell therapies for treating diabetes: progress and remaining challenges. Cell Stem Cell. 2018;22(6):810\u201323.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"786_CR7","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1056\/NEJM200007273430401","volume":"343","author":"AM Shapiro","year":"2000","unstructured":"Shapiro AM, Lakey JR, Ryan EA, Korbutt GS, Toth E, Warnock GL, et\u00a0al. Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen. N Engl J Med. 2000;343(4):230\u20138.","journal-title":"N Engl J Med"},{"issue":"13","key":"786_CR8","doi-asserted-by":"publisher","first-page":"1318","DOI":"10.1056\/NEJMoa061267","volume":"355","author":"AM Shapiro","year":"2006","unstructured":"Shapiro AM, Ricordi C, Hering BJ, Auchincloss H, Lindblad R, Robertson RP, et\u00a0al. International trial of the Edmonton protocol for islet transplantation. N Engl J Med. 2006;355(13):1318\u201330.","journal-title":"N Engl J Med"},{"issue":"7","key":"786_CR9","doi-asserted-by":"publisher","first-page":"704","DOI":"10.1093\/stcltm\/szac030","volume":"11","author":"B Memon","year":"2022","unstructured":"Memon B, Abdelalim EM. Toward precision medicine with human pluripotent stem cells for diabetes. Stem Cells Transl Med. 2022;11(7):704\u201314.","journal-title":"Stem Cells Transl Med"},{"issue":"1","key":"786_CR10","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s41232-020-00152-5","volume":"41","author":"EZ Sim","year":"2021","unstructured":"Sim EZ, Shiraki N, Kume S. Recent progress in pancreatic islet cell therapy. Inflamm Regen. 2021;41(1):1.","journal-title":"Inflamm Regen"},{"issue":"1","key":"786_CR11","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1007\/s00467-008-1020-x","volume":"25","author":"E Ingulli","year":"2010","unstructured":"Ingulli E. Mechanism of cellular rejection in transplantation. Pediatr Nephrol. 2010;25(1):61-74. https:\/\/doi.org\/10.1007\/s00467-008-1020-x.","journal-title":"Pediatr Nephrol"},{"issue":"6","key":"786_CR12","doi-asserted-by":"publisher","DOI":"10.1111\/tan.15549","volume":"103","author":"J Robinson","year":"2024","unstructured":"Robinson J, Barker DJ, Marsh SGE. 25 years of the IPD-IMGT\/HLA database. HLA. 2024;103(6): e15549.","journal-title":"HLA"},{"key":"786_CR13","doi-asserted-by":"crossref","unstructured":"Tak W. Mak, Mary E. Saunders, Jett BD. Chapter 6 - The Major Histocompatibility complex. Academic Cell. 2014(Primer to the Immune Response (Second Edition)):143\u201359.","DOI":"10.1016\/B978-0-12-385245-8.00006-6"},{"issue":"4","key":"786_CR14","doi-asserted-by":"publisher","first-page":"448","DOI":"10.4103\/0366-6999.176084","volume":"129","author":"L Li","year":"2016","unstructured":"Li L, Dong M, Wang XG. The implication and significance of beta 2 microglobulin: a conservative multifunctional regulator. Chin Med J Engl. 2016;129(4):448\u201355.","journal-title":"Chin Med J Engl"},{"issue":"3","key":"786_CR15","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1365-2567.2010.03398.x","volume":"132","author":"KS Campbell","year":"2011","unstructured":"Campbell KS, Purdy AK. Structure\/function of human killer cell immunoglobulin-like receptors: lessons from polymorphisms, evolution, crystal structures and mutations. Immunology. 2011;132(3):315\u201325.","journal-title":"Immunology"},{"issue":"2","key":"786_CR16","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.jaci.2014.06.001","volume":"134","author":"S Hanna","year":"2014","unstructured":"Hanna S, Etzioni A. MHC class I and II deficiencies. J Allergy Clin Immunol. 2014;134(2):269\u201375.","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"786_CR17","doi-asserted-by":"publisher","first-page":"504","DOI":"10.1038\/gt.2012.59","volume":"20","author":"M Haruta","year":"2013","unstructured":"Haruta M, Tomita Y, Yuno A, Matsumura K, Ikeda T, Takamatsu K, et\u00a0al. TAP-deficient human iPS cell-derived myeloid cell lines as unlimited cell source for dendritic cell-like antigen-presenting cells. Gene Ther. 2013;20(5):504\u201313.","journal-title":"Gene Ther"},{"issue":"8","key":"786_CR18","doi-asserted-by":"publisher","first-page":"4187","DOI":"10.4049\/jimmunol.171.8.4187","volume":"171","author":"M Giroux","year":"2003","unstructured":"Giroux M, Schmidt M, Descoteaux A. IFN-gamma-induced MHC class II expression: transactivation of class II transactivator promoter IV by IFN regulatory factor-1 is regulated by protein kinase C-alpha. J Immunol. 2003;171(8):4187\u201394.","journal-title":"J Immunol"},{"issue":"2","key":"786_CR19","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1007\/s00125-021-05619-9","volume":"65","author":"E Quesada-Masachs","year":"2022","unstructured":"Quesada-Masachs E, Zilberman S, Rajendran S, Chu T, McArdle S, Kiosses WB, et\u00a0al. Upregulation of HLA class II in pancreatic beta cells from organ donors with type 1 diabetes. Diabetologia. 2022;65(2):387\u2013401.","journal-title":"Diabetologia"},{"key":"786_CR20","doi-asserted-by":"publisher","first-page":"832","DOI":"10.3389\/fimmu.2017.00832","volume":"8","author":"NB Crux","year":"2017","unstructured":"Crux NB, Elahi S. Human leukocyte antigen (HLA) and immune regulation: how do classical and non-classical HLA alleles modulate immune response to human immunodeficiency virus and hepatitis C virus infections? Front Immunol. 2017;8:832.","journal-title":"Front Immunol"},{"issue":"5","key":"786_CR21","doi-asserted-by":"publisher","first-page":"1557","DOI":"10.1182\/blood-2008-05-078154","volume":"112","author":"J Zhu","year":"2008","unstructured":"Zhu J, Paul WE. CD4 T cells: fates, functions, and faults. Blood. 2008;112(5):1557\u201369.","journal-title":"Blood"},{"issue":"4","key":"786_CR22","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1111\/j.1365-3083.2009.02308.x","volume":"70","author":"A Corthay","year":"2009","unstructured":"Corthay A. How do regulatory T cells work? Scand J Immunol. 2009;70(4):326\u201336.","journal-title":"Scand J Immunol"},{"issue":"4","key":"786_CR23","doi-asserted-by":"publisher","first-page":"1367","DOI":"10.1084\/jem.180.4.1367","volume":"180","author":"CH Chang","year":"1994","unstructured":"Chang CH, Fontes JD, Peterlin M, Flavell RA. Class II transactivator (CIITA) is sufficient for the inducible expression of major histocompatibility complex class II genes. J Exp Med. 1994;180(4):1367\u201374.","journal-title":"J Exp Med"},{"issue":"5168","key":"786_CR24","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1126\/science.8016643","volume":"265","author":"V Steimle","year":"1994","unstructured":"Steimle V, Siegrist CA, Mottet A, Lisowska-Grospierre B, Mach B. Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA. Science. 1994;265(5168):106\u20139.","journal-title":"Science"},{"key":"786_CR25","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/978-1-62703-478-4_1","volume":"1029","author":"N Ichiryu","year":"2013","unstructured":"Ichiryu N, Fairchild PJ. Immune privilege of stem cells. Methods Mol Biol. 2013;1029:1\u201316.","journal-title":"Methods Mol Biol"},{"issue":"3","key":"786_CR26","doi-asserted-by":"publisher","first-page":"610","DOI":"10.1097\/00007890-198803000-00021","volume":"45","author":"D Abi-Hanna","year":"1988","unstructured":"Abi-Hanna D, Wakefield D, Watkins S. HLA antigens in ocular tissues. I. in\u00a0vivo expression in human eyes. Transplantation. 1988;45(3):610\u20133.","journal-title":"Transplantation"},{"issue":"8","key":"786_CR27","doi-asserted-by":"publisher","first-page":"584","DOI":"10.1038\/nri1897","volume":"6","author":"A Moffett","year":"2006","unstructured":"Moffett A, Loke C. Immunology of placentation in eutherian mammals. Nat Rev Immunol. 2006;6(8):584\u201394.","journal-title":"Nat Rev Immunol"},{"issue":"4","key":"786_CR28","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1159\/000067596","volume":"129","author":"MK Levings","year":"2002","unstructured":"Levings MK, Bacchetta R, Schulz U, Roncarolo MG. The role of IL-10 and TGF-beta in the differentiation and effector function of T regulatory cells. Int Arch Allergy Immunol. 2002;129(4):263\u201376.","journal-title":"Int Arch Allergy Immunol"},{"key":"786_CR29","doi-asserted-by":"publisher","DOI":"10.1016\/j.biopha.2020.110921","volume":"133","author":"R Wei","year":"2021","unstructured":"Wei R, Lai N, Zhao L, Zhang Z, Zhu X, Guo Q, et\u00a0al. Dendritic cells in pregnancy and pregnancy-associated diseases. Biomed Pharmacother. 2021;133: 110921.","journal-title":"Biomed Pharmacother"},{"issue":"9","key":"786_CR30","doi-asserted-by":"publisher","first-page":"3173","DOI":"10.1210\/jcem.82.9.4360","volume":"82","author":"AM Bamberger","year":"1997","unstructured":"Bamberger AM, Schulte HM, Thuneke I, Erdmann I, Bamberger CM, Asa SL. Expression of the apoptosis-inducing Fas ligand (FasL) in human first and third trimester placenta and choriocarcinoma cells. J Clin Endocrinol Metab. 1997;82(9):3173\u20135.","journal-title":"J Clin Endocrinol Metab"},{"issue":"6550","key":"786_CR31","doi-asserted-by":"publisher","first-page":"630","DOI":"10.1038\/377630a0","volume":"377","author":"D Bellgrau","year":"1995","unstructured":"Bellgrau D, Gold D, Selawry H, Moore J, Franzusoff A, Duke RC. A role for CD95 ligand in preventing graft rejection. Nature. 1995;377(6550):630\u20132.","journal-title":"Nature"},{"issue":"8","key":"786_CR32","doi-asserted-by":"publisher","first-page":"3806","DOI":"10.4049\/jimmunol.154.8.3806","volume":"154","author":"T Suda","year":"1995","unstructured":"Suda T, Okazaki T, Naito Y, Yokota T, Arai N, Ozaki S, et\u00a0al. Expression of the Fas ligand in cells of T cell lineage. J Immunol. 1995;154(8):3806\u201313.","journal-title":"J Immunol"},{"issue":"1","key":"786_CR33","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1016\/S1074-7613(00)80305-2","volume":"5","author":"TS Griffith","year":"1996","unstructured":"Griffith TS, Yu X, Herndon JM, Green DR, Ferguson TA. CD95-induced apoptosis of lymphocytes in an immune privileged site induces immunological tolerance. Immunity. 1996;5(1):7\u201316.","journal-title":"Immunity"},{"issue":"8","key":"786_CR34","doi-asserted-by":"publisher","first-page":"846","DOI":"10.1038\/cr.2008.80","volume":"18","author":"H Sheng","year":"2008","unstructured":"Sheng H, Wang Y, Jin Y, Zhang Q, Zhang Y, Wang L, et\u00a0al. A critical role of IFNgamma in priming MSC-mediated suppression of T cell proliferation through up-regulation of B7\u2013H1. Cell Res. 2008;18(8):846\u201357.","journal-title":"Cell Res"},{"issue":"8","key":"786_CR35","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1038\/nm730","volume":"8","author":"H Dong","year":"2002","unstructured":"Dong H, Strome SE, Salomao DR, Tamura H, Hirano F, Flies DB, et\u00a0al. Tumor-associated B7\u2013H1 promotes T-cell apoptosis: a potential mechanism of immune evasion. Nat Med. 2002;8(8):793\u2013800.","journal-title":"Nat Med"},{"issue":"5","key":"786_CR36","doi-asserted-by":"publisher","first-page":"437","DOI":"10.1097\/MOT.0000000000000448","volume":"22","author":"CA Chang","year":"2017","unstructured":"Chang CA, Lawrence MC, Naziruddin B. Current issues in allogeneic islet transplantation. Curr Opin Organ Transplant. 2017;22(5):437\u201343.","journal-title":"Curr Opin Organ Transplant"},{"issue":"3","key":"786_CR37","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.stem.2024.02.001","volume":"31","author":"X Hu","year":"2024","unstructured":"Hu X, White K, Young C, Olroyd AG, Kievit P, Connolly AJ, et\u00a0al. Hypoimmune islets achieve insulin independence after allogeneic transplantation in a fully immunocompetent non-human primate. Cell Stem Cell. 2024;31(3):334-40 e5.","journal-title":"Cell Stem Cell"},{"key":"786_CR38","unstructured":"Sana biotechnology announces positive clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression [press release]. Globe Newswire, Jan 2025."},{"key":"786_CR39","unstructured":"Sana biotechnology announces positive six-month clinical results from type 1 diabetes study of islet cell transplantation without immunosuppression [press release]. Globe Newswire 2025."},{"issue":"3","key":"786_CR40","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1038\/s41587-019-0016-3","volume":"37","author":"T Deuse","year":"2019","unstructured":"Deuse T, Hu X, Gravina A, Wang D, Tediashvili G, De C, et\u00a0al. Hypoimmunogenic derivatives of induced pluripotent stem cells evade immune rejection in fully immunocompetent allogeneic recipients. Nat Biotechnol. 2019;37(3):252\u20138.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"786_CR41","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1038\/nbt.2623","volume":"31","author":"Y Fu","year":"2013","unstructured":"Fu Y, Foden JA, Khayter C, Maeder ML, Reyon D, Joung JK, et\u00a0al. High-frequency off-target mutagenesis induced by CRISPR-Cas nucleases in human cells. Nat Biotechnol. 2013;31(9):822\u20136.","journal-title":"Nat Biotechnol"},{"issue":"9","key":"786_CR42","doi-asserted-by":"publisher","first-page":"827","DOI":"10.1038\/nbt.2647","volume":"31","author":"PD Hsu","year":"2013","unstructured":"Hsu PD, Scott DA, Weinstein JA, Ran FA, Konermann S, Agarwala V, et\u00a0al. DNA targeting specificity of RNA-guided Cas9 nucleases. Nat Biotechnol. 2013;31(9):827\u201332.","journal-title":"Nat Biotechnol"},{"issue":"5","key":"786_CR43","doi-asserted-by":"publisher","first-page":"268","DOI":"10.1038\/nrendo.2016.178","volume":"13","author":"AM Shapiro","year":"2017","unstructured":"Shapiro AM, Pokrywczynska M, Ricordi C. Clinical pancreatic islet transplantation. Nat Rev Endocrinol. 2017;13(5):268\u201377.","journal-title":"Nat Rev Endocrinol"},{"issue":"1","key":"786_CR44","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1186\/s13287-022-03233-z","volume":"14","author":"Y Chen","year":"2023","unstructured":"Chen Y, Zhou Y, Zhou Z, Fang Y, Ma L, Zhang X, et\u00a0al. Hypoimmunogenic human pluripotent stem cells are valid cell sources for cell therapeutics with normal self-renewal and multilineage differentiation capacity. Stem Cell Res Ther. 2023;14(1):11.","journal-title":"Stem Cell Res Ther"},{"key":"786_CR45","doi-asserted-by":"publisher","DOI":"10.3390\/cells9020283","author":"B Memon","year":"2020","unstructured":"Memon B, Abdelalim EM. Stem cell therapy for diabetes: beta cells versus pancreatic progenitors. Cells. 2020. https:\/\/doi.org\/10.3390\/cells9020283.","journal-title":"Cells"},{"issue":"4","key":"786_CR46","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1016\/j.stemcr.2015.02.017","volume":"4","author":"MC Nostro","year":"2015","unstructured":"Nostro MC, Sarangi F, Yang C, Holland A, Elefanty AG, Stanley EG, et\u00a0al. Efficient generation of NKX6-1+ pancreatic progenitors from multiple human pluripotent stem cell lines. Stem Cell Reports. 2015;4(4):591\u2013604.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"786_CR47","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-017-0759-z","volume":"9","author":"B Memon","year":"2018","unstructured":"Memon B, Karam M, Al-Khawaga S, Abdelalim EM. Enhanced differentiation of human pluripotent stem cells into pancreatic progenitors co-expressing PDX1 and NKX6.1. Stem Cell Res Ther. 2018;9(1): 15.","journal-title":"Stem Cell Res Ther"},{"key":"786_CR48","doi-asserted-by":"publisher","DOI":"10.3389\/fgeed.2021.673022","volume":"3","author":"A Atkins","year":"2021","unstructured":"Atkins A, Chung CH, Allen AG, Dampier W, Gurrola TE, Sariyer IK, et\u00a0al. Off-target analysis in gene editing and applications for clinical translation of CRISPR\/Cas9 in HIV-1 therapy. Front Genome Ed. 2021;3: 673022.","journal-title":"Front Genome Ed"},{"key":"786_CR49","doi-asserted-by":"publisher","first-page":"1143157","DOI":"10.3389\/fbioe.2023.1143157","volume":"11","author":"C Guo","year":"2023","unstructured":"Guo C, Ma X, Gao F, Guo Y. Off-target effects in CRISPR\/Cas9 gene editing. Front Bioeng Biotechnol. 2023;11:1143157.","journal-title":"Front Bioeng Biotechnol"},{"issue":"2","key":"786_CR50","doi-asserted-by":"publisher","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","volume":"159","author":"FW Pagliuca","year":"2014","unstructured":"Pagliuca FW, Millman JR, Gurtler M, Segel M, Van Dervort A, Ryu JH, et\u00a0al. Generation of functional human pancreatic beta cells in\u00a0vitro. Cell. 2014;159(2):428\u201339.","journal-title":"Cell"},{"issue":"11","key":"786_CR51","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1038\/nbt.3033","volume":"32","author":"A Rezania","year":"2014","unstructured":"Rezania A, Bruin JE, Arora P, Rubin A, Batushansky I, Asadi A, et\u00a0al. Reversal of diabetes with insulin-producing cells derived in\u00a0vitro from human pluripotent stem cells. Nat Biotechnol. 2014;32(11):1121\u201333.","journal-title":"Nat Biotechnol"},{"issue":"4","key":"786_CR52","doi-asserted-by":"publisher","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","volume":"38","author":"NJ Hogrebe","year":"2020","unstructured":"Hogrebe NJ, Augsornworawat P, Maxwell KG, Velazco-Cruz L, Millman JR. Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells. Nat Biotechnol. 2020;38(4):460\u201370.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"786_CR53","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","volume":"12","author":"L Velazco-Cruz","year":"2019","unstructured":"Velazco-Cruz L, Song J, Maxwell KG, Goedegebuure MM, Augsornworawat P, Hogrebe NJ, et\u00a0al. Acquisition of dynamic function in human stem cell-derived beta cells. Stem Cell Rep. 2019;12(2):351\u201365.","journal-title":"Stem Cell Rep"},{"issue":"2","key":"786_CR54","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","volume":"21","author":"GG Nair","year":"2019","unstructured":"Nair GG, Liu JS, Russ HA, Tran S, Saxton MS, Chen R, et\u00a0al. Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived beta cells. Nat Cell Biol. 2019;21(2):263\u201374.","journal-title":"Nat Cell Biol"},{"issue":"13","key":"786_CR55","doi-asserted-by":"publisher","first-page":"1759","DOI":"10.15252\/embj.201591058","volume":"34","author":"HA Russ","year":"2015","unstructured":"Russ HA, Parent AV, Ringler JJ, Hennings TG, Nair GG, Shveygert M, et\u00a0al. Controlled induction of human pancreatic progenitors produces functional beta-like cells in\u00a0vitro. EMBO J. 2015;34(13):1759\u201372.","journal-title":"EMBO J"},{"issue":"7756","key":"786_CR56","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1038\/s41586-019-1168-5","volume":"569","author":"A Veres","year":"2019","unstructured":"Veres A, Faust AL, Bushnell HL, Engquist EN, Kenty JH, Harb G, et\u00a0al. Charting cellular identity during human in\u00a0vitro beta-cell differentiation. Nature. 2019;569(7756):368\u201373.","journal-title":"Nature"},{"issue":"1","key":"786_CR57","doi-asserted-by":"publisher","first-page":"1464","DOI":"10.1038\/s41467-019-09404-6","volume":"10","author":"EA Rosado-Olivieri","year":"2019","unstructured":"Rosado-Olivieri EA, Anderson K, Kenty JH, Melton DA. Yap inhibition enhances the differentiation of functional stem cell-derived insulin-producing beta cells. Nat Commun. 2019;10(1):1464.","journal-title":"Nat Commun"},{"issue":"7","key":"786_CR58","doi-asserted-by":"publisher","first-page":"1042","DOI":"10.1038\/s41587-022-01219-z","volume":"40","author":"D Balboa","year":"2022","unstructured":"Balboa D, Barsby T, Lithovius V, Saarimaki-Vire J, Omar-Hmeadi M, Dyachok O, et\u00a0al. Functional, metabolic and transcriptional maturation of human pancreatic islets derived from stem cells. Nat Biotechnol. 2022;40(7):1042\u201355.","journal-title":"Nat Biotechnol"},{"issue":"2","key":"786_CR59","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1038\/s41591-021-01645-7","volume":"28","author":"Y Du","year":"2022","unstructured":"Du Y, Liang Z, Wang S, Sun D, Wang X, Liew SY, et\u00a0al. Human pluripotent stem-cell-derived islets ameliorate diabetes in non-human primates. Nat Med. 2022;28(2):272\u201382.","journal-title":"Nat Med"},{"issue":"3","key":"786_CR60","doi-asserted-by":"publisher","first-page":"227","DOI":"10.1111\/tri.12919","volume":"30","author":"V Delaune","year":"2017","unstructured":"Delaune V, Berney T, Lacotte S, Toso C. Intraportal islet transplantation: the impact of the liver microenvironment. Transplant Int. 2017;30(3):227\u201338.","journal-title":"Transplant Int"},{"issue":"5","key":"786_CR61","doi-asserted-by":"publisher","first-page":"1111","DOI":"10.2337\/db16-1406","volume":"66","author":"JR Millman","year":"2017","unstructured":"Millman JR, Pagliuca FW. Autologous pluripotent stem cell-derived \u03b2-like cells for diabetes cellular therapy. Diabetes. 2017;66(5):1111\u201320.","journal-title":"Diabetes"},{"issue":"1","key":"786_CR62","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1038\/s41421-024-00662-3","volume":"10","author":"J Wu","year":"2024","unstructured":"Wu J, Li T, Guo M, Ji J, Meng X, Fu T, et\u00a0al. Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue. Cell Discov. 2024;10(1):45.","journal-title":"Cell Discov"},{"key":"786_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2024.09.004","author":"S Wang","year":"2024","unstructured":"Wang S, Du Y, Zhang B, Meng G, Liu Z, Liew SY, et\u00a0al. Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient. Cell. 2024. https:\/\/doi.org\/10.1016\/j.cell.2024.09.004.","journal-title":"Cell"},{"issue":"7350","key":"786_CR64","doi-asserted-by":"publisher","first-page":"212","DOI":"10.1038\/nature10135","volume":"474","author":"T Zhao","year":"2011","unstructured":"Zhao T, Zhang ZN, Rong Z, Xu Y. Immunogenicity of induced pluripotent stem cells. Nature. 2011;474(7350):212\u20135.","journal-title":"Nature"},{"issue":"3","key":"786_CR65","doi-asserted-by":"publisher","first-page":"353","DOI":"10.1016\/j.stem.2015.07.021","volume":"17","author":"T Zhao","year":"2015","unstructured":"Zhao T, Zhang ZN, Westenskow PD, Todorova D, Hu Z, Lin T, et\u00a0al. Humanized mice reveal differential immunogenicity of cells derived from autologous induced pluripotent stem cells. Cell Stem Cell. 2015;17(3):353\u20139.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"786_CR66","doi-asserted-by":"publisher","first-page":"2155","DOI":"10.1007\/s12015-024-10783-7","volume":"20","author":"R Escrib\u00e1","year":"2024","unstructured":"Escrib\u00e1 R, Beksac M, Bennaceur-Griscelli A, Glover JC, Koskela S, Latsoudis H, et\u00a0al. Current landscape of iPSC haplobanks. Stem Cell Rev Rep. 2024;20(8):2155\u201364.","journal-title":"Stem Cell Rev Rep"},{"key":"786_CR67","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2016.00575","volume":"7","author":"AA Zachary","year":"2016","unstructured":"Zachary AA, Leffell MS. HLA mismatching strategies for solid organ transplantation\u2014A balancing act. Front Immunol. 2016;7: 575.","journal-title":"Front Immunol"},{"issue":"5","key":"786_CR68","doi-asserted-by":"publisher","first-page":"1094","DOI":"10.1097\/TP.0000000000001115","volume":"100","author":"RC Williams","year":"2016","unstructured":"Williams RC, Opelz G, McGarvey CJ, Weil EJ, Chakkera HA. The risk of transplant failure with HLA mismatch in first adult kidney allografts from deceased donors. Transplantation. 2016;100(5):1094\u2013102.","journal-title":"Transplantation"},{"key":"786_CR69","doi-asserted-by":"publisher","DOI":"10.1016\/j.scr.2020.102033","volume":"50","author":"T Hanatani","year":"2021","unstructured":"Hanatani T, Takasu N. CiRA iPSC seed stocks (CiRA\u2019s iPSC stock project). Stem Cell Res. 2021;50: 102033.","journal-title":"Stem Cell Res"},{"issue":"3","key":"786_CR70","doi-asserted-by":"publisher","first-page":"e1531","DOI":"10.1002\/term.2578","volume":"12","author":"YA Rim","year":"2018","unstructured":"Rim YA, Park N, Nam Y, Ham D-S, Kim J-W, Ha H-Y, et\u00a0al. Recent progress of national banking project on homozygous HLA-typed induced pluripotent stem cells in South Korea. J Tissue Eng Regen Med. 2018;12(3):e1531\u20136.","journal-title":"J Tissue Eng Regen Med"},{"issue":"10","key":"786_CR71","doi-asserted-by":"publisher","first-page":"1552","DOI":"10.1002\/stem.2865","volume":"36","author":"S Lee","year":"2018","unstructured":"Lee S, Huh JY, Turner DM, Lee S, Robinson J, Stein JE, et\u00a0al. Repurposing the cord blood bank for haplobanking of HLA-homozygous iPSCs and their usefulness to multiple populations. Stem Cells. 2018;36(10):1552\u201366.","journal-title":"Stem Cells"},{"issue":"1","key":"786_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13287-023-03576-1","volume":"14","author":"B Kuebler","year":"2023","unstructured":"Kuebler B, Alvarez-Palomo B, Aran B, Casta\u00f1o J, Rodriguez L, Raya A, et\u00a0al. Generation of a bank of clinical-grade, HLA-homozygous iPSC lines with high coverage of the Spanish population. Stem Cell Res Ther. 2023;14(1): 366.","journal-title":"Stem Cell Res Ther"},{"key":"786_CR73","unstructured":"Paris-Saclay U. CiTHERA, a new laboratory for the production of therapeutic stem cells: University Paris-Saclay; 2021 [Available from: https:\/\/news.universite-paris-saclay.fr\/en\/news\/cithera-new-laboratory-production-therapeutic-stem-cells."},{"issue":"1","key":"786_CR74","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1111\/vox.12978","volume":"116","author":"S Liedtke","year":"2021","unstructured":"Liedtke S, Korschgen L, Korn J, Duppers A, Kogler G. GMP-grade CD34+ selection from HLA-homozygous licensed cord blood units and short-term expansion under European ATMP regulations. Vox Sang. 2021;116(1):123\u201335.","journal-title":"Vox Sang"},{"issue":"7","key":"786_CR75","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1016\/j.humimm.2018.04.012","volume":"79","author":"A Lande","year":"2018","unstructured":"Lande A, Andersen I, Egeland T, Lie BA, Viken MK. HLA -A, -C, -B, -DRB1, -DQB1 and -DPB1 allele and haplotype frequencies in 4514 healthy Norwegians. Hum Immunol. 2018;79(7):527\u20139.","journal-title":"Hum Immunol"},{"key":"786_CR76","unstructured":"Rubinstein P. HLA homozygous induced pluripotent stem cell (iPSC) libraries 2019. https:\/\/patents.google.com\/patent\/WO2019113169A2\/en."},{"issue":"1","key":"786_CR77","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1186\/s13287-023-03612-0","volume":"14","author":"M Alowaysi","year":"2023","unstructured":"Alowaysi M, Lehmann R, Al-Shehri M, Baadhaim M, Alzahrani H, Aboalola D, et\u00a0al. Hla-based banking of induced pluripotent stem cells in Saudi Arabia. Stem Cell Res Ther. 2023;14(1):374.","journal-title":"Stem Cell Res Ther"},{"issue":"8","key":"786_CR78","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1016\/j.humimm.2010.05.013","volume":"71","author":"M-J Lai","year":"2010","unstructured":"Lai M-J, Wen S-H, Lin Y-H, Shyr M-H, Lin P-Y, Yang K-L. Distributions of human leukocyte antigen\u2013A, \u2013B, and \u2013DRB1 alleles and haplotypes based on 46,915 Taiwanese donors. Hum Immunol. 2010;71(8):777\u201382.","journal-title":"Hum Immunol"},{"issue":"1","key":"786_CR79","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.medj.2022.10.003","volume":"4","author":"S Yoshida","year":"2023","unstructured":"Yoshida S, Kato TM, Sato Y, Umekage M, Ichisaka T, Tsukahara M, et\u00a0al. A clinical-grade HLA haplobank of human induced pluripotent stem cells matching approximately 40% of the Japanese population. Med. 2023;4(1):51-66.e10.","journal-title":"Med"},{"issue":"5","key":"786_CR80","doi-asserted-by":"publisher","first-page":"409","DOI":"10.1038\/nmeth.1591","volume":"8","author":"K Okita","year":"2011","unstructured":"Okita K, Matsumura Y, Sato Y, Okada A, Morizane A, Okamoto S, et\u00a0al. A more efficient method to generate integration-free human iPS cells. Nat Methods. 2011;8(5):409\u201312.","journal-title":"Nat Methods"},{"issue":"2","key":"786_CR81","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.stem.2012.07.014","volume":"11","author":"CJ Taylor","year":"2012","unstructured":"Taylor CJ, Peacock S, Chaudhry AN, Bradley JA, Bolton EM. Generating an iPSC bank for HLA-matched tissue transplantation based on known donor and recipient HLA types. Cell Stem Cell. 2012;11(2):147\u201352.","journal-title":"Cell Stem Cell"},{"issue":"1","key":"786_CR82","doi-asserted-by":"publisher","first-page":"6","DOI":"10.31662\/jmaj.2018-0005","volume":"1","author":"P Karagiannis","year":"2018","unstructured":"Karagiannis P, Nakauchi A, Yamanaka S. Bringing induced pluripotent stem cell technology to the bedside. JMA J. 2018;1(1):6\u201314.","journal-title":"JMA J"},{"issue":"5, Supplement","key":"786_CR83","doi-asserted-by":"publisher","first-page":"S233","DOI":"10.1016\/j.jcyt.2025.03.480","volume":"27","author":"B Hiller","year":"2025","unstructured":"Hiller B, Tr\u00e4ger C, Henschel N, Lichte J, Terheyden-Keighley D, Berger T, et\u00a0al. Off-the-Shelf GMP-compliant iPS cells for application in cell therapy. Cytotherapy. 2025;27(5, Supplement):S233\u20134.","journal-title":"Cytotherapy"},{"issue":"3","key":"786_CR84","doi-asserted-by":"publisher","first-page":"306","DOI":"10.1038\/nm.4030","volume":"22","author":"AJ Vegas","year":"2016","unstructured":"Vegas AJ, Veiseh O, Gurtler M, Millman JR, Pagliuca FW, Bader AR, et\u00a0al. Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice. Nat Med. 2016;22(3):306\u201311.","journal-title":"Nat Med"},{"issue":"5","key":"786_CR85","doi-asserted-by":"publisher","first-page":"338","DOI":"10.1038\/nrd.2016.232","volume":"16","author":"T Desai","year":"2017","unstructured":"Desai T, Shea LD. Advances in islet encapsulation technologies. Nat Rev Drug Discov. 2017;16(5):338\u201350.","journal-title":"Nat Rev Drug Discov"},{"key":"786_CR86","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1007\/978-3-319-18603-0_7","volume":"865","author":"LB Moore","year":"2015","unstructured":"Moore LB, Kyriakides TR. Molecular characterization of macrophage-biomaterial interactions. Adv Exp Med Biol. 2015;865:109\u201322.","journal-title":"Adv Exp Med Biol"},{"issue":"2","key":"786_CR87","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1016\/j.smim.2007.11.004","volume":"20","author":"JM Anderson","year":"2008","unstructured":"Anderson JM, Rodriguez A, Chang DT. Foreign body reaction to biomaterials. Semin Immunol. 2008;20(2):86\u2013100.","journal-title":"Semin Immunol"},{"key":"786_CR88","doi-asserted-by":"publisher","first-page":"184","DOI":"10.1016\/j.addr.2017.07.006","volume":"114","author":"L Chung","year":"2017","unstructured":"Chung L, Maestas DR Jr, Housseau F, Elisseeff JH. Key players in the immune response to biomaterial scaffolds for regenerative medicine. Adv Drug Deliv Rev. 2017;114:184\u201392.","journal-title":"Adv Drug Deliv Rev"},{"key":"786_CR89","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.actbio.2022.11.003","volume":"155","author":"D Salthouse","year":"2023","unstructured":"Salthouse D, Novakovic K, Hilkens CMU, Ferreira AM. Interplay between biomaterials and the immune system: challenges and opportunities in regenerative medicine. Acta Biomater. 2023;155:1\u201318.","journal-title":"Acta Biomater"},{"key":"786_CR90","doi-asserted-by":"publisher","unstructured":"Robert R. Henry, Jeremy Pettus, Jon Wilensky, A.M. James Shapiro, Peter A. Senior, Bart Roep, Richard Wang, Evert J. Kroon, Michael Scott, Kevin D'amour, Howard L. Foyt; Initial Clinical Evaluation of VC-01TM Combination Product\u2014A Stem Cell\u2013Derived Islet Replacement for Type 1 Diabetes (T1D). Diabetes 1 July 2018; 67 (Supplement_1): 138\u2013OR. https:\/\/doi.org\/10.2337\/db18-138-OR.","DOI":"10.2337\/db18-138-OR"},{"issue":"8","key":"786_CR91","doi-asserted-by":"publisher","first-page":"1223","DOI":"10.1097\/TP.0000000000002217","volume":"102","author":"J Odorico","year":"2018","unstructured":"Odorico J, Markmann J, Melton D, Greenstein J, Hwa A, Nostro C, et\u00a0al. Report of the key opinion leaders meeting on stem cell-derived beta cells. Transplantation. 2018;102(8):1223\u20139.","journal-title":"Transplantation"},{"issue":"12","key":"786_CR92","doi-asserted-by":"publisher","first-page":"2047","DOI":"10.1016\/j.stem.2021.10.003","volume":"28","author":"A Ramzy","year":"2021","unstructured":"Ramzy A, Thompson DM, Ward-Hartstonge KA, Ivison S, Cook L, Garcia RV, et\u00a0al. Implanted pluripotent stem-cell-derived pancreatic endoderm cells secrete glucose-responsive C-peptide in patients with type 1 diabetes. Cell Stem Cell. 2021;28(12):2047-61.e5.","journal-title":"Cell Stem Cell"},{"key":"786_CR93","unstructured":"Vertex announces program updates for type 1 diabetes portfolio [press release]. Business Wire 2025."},{"issue":"5","key":"786_CR94","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s12015-022-10369-1","volume":"18","author":"D Jovic","year":"2022","unstructured":"Jovic D, Yu Y, Wang D, Wang K, Li H, Xu F, et\u00a0al. A brief overview of global trends in MSC-based cell therapy. Stem Cell Rev Rep. 2022;18(5):1525\u201345.","journal-title":"Stem Cell Rev Rep"},{"issue":"5","key":"786_CR95","doi-asserted-by":"publisher","first-page":"1246","DOI":"10.1634\/stemcells.2005-0235","volume":"24","author":"K McIntosh","year":"2006","unstructured":"McIntosh K, Zvonic S, Garrett S, Mitchell JB, Floyd ZE, Hammill L, et\u00a0al. The immunogenicity of human adipose-derived cells: temporal changes in\u00a0vitro. Stem Cells. 2006;24(5):1246\u201353.","journal-title":"Stem Cells"},{"issue":"1","key":"786_CR96","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1111\/j.1365-2141.2005.05409.x","volume":"129","author":"B Puissant","year":"2005","unstructured":"Puissant B, Barreau C, Bourin P, Clavel C, Corre J, Bousquet C, et\u00a0al. Immunomodulatory effect of human adipose tissue-derived adult stem cells: comparison with bone marrow mesenchymal stem cells. Br J Haematol. 2005;129(1):118\u201329.","journal-title":"Br J Haematol"},{"issue":"6","key":"786_CR97","doi-asserted-by":"publisher","first-page":"631","DOI":"10.1016\/j.bbmt.2008.01.006","volume":"14","author":"FE Ezquer","year":"2008","unstructured":"Ezquer FE, Ezquer ME, Parrau DB, Carpio D, Ya\u00f1ez AJ, Conget PA. Systemic administration of multipotent mesenchymal stromal cells reverts hyperglycemia and prevents nephropathy in type 1 diabetic mice. Biol Blood Marrow Transplant. 2008;14(6):631\u201340.","journal-title":"Biol Blood Marrow Transplant"},{"issue":"46","key":"786_CR98","doi-asserted-by":"publisher","first-page":"17438","DOI":"10.1073\/pnas.0608249103","volume":"103","author":"RH Lee","year":"2006","unstructured":"Lee RH, Seo MJ, Reger RL, Spees JL, Pulin AA, Olson SD, et\u00a0al. Multipotent stromal cells from human marrow home to and promote repair of pancreatic islets and renal glomeruli in diabetic NOD\/scid mice. Proc Natl Acad Sci. 2006;103(46):17438\u201343.","journal-title":"Proc Natl Acad Sci"},{"key":"786_CR99","doi-asserted-by":"publisher","first-page":"690623","DOI":"10.3389\/fimmu.2021.690623","volume":"12","author":"AF Refaie","year":"2021","unstructured":"Refaie AF, Elbassiouny BL, Kloc M, Sabek OM, Khater SM, Ismail AM, et\u00a0al. From mesenchymal stromal\/stem cells to insulin-producing cells: immunological considerations. Front Immunol. 2021;12:690623.","journal-title":"Front Immunol"},{"issue":"3","key":"786_CR100","doi-asserted-by":"publisher","first-page":"194","DOI":"10.1159\/000128968","volume":"35","author":"F Bifari","year":"2008","unstructured":"Bifari F, Lisi V, Mimiola E, Pasini A, Krampera M. Immune modulation by mesenchymal stem cells. Transfus Med Hemother. 2008;35(3):194\u2013204.","journal-title":"Transfus Med Hemother"},{"issue":"8","key":"786_CR101","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1007\/s00125-023-05934-3","volume":"66","author":"P-O Carlsson","year":"2023","unstructured":"Carlsson P-O, Espes D, Sisay S, Davies LC, Smith CIE, Svahn MG. Umbilical cord-derived mesenchymal stromal cells preserve endogenous insulin production in type 1 diabetes: a phase I\/II randomised double-blind placebo-controlled trial. Diabetologia. 2023;66(8):1431\u201341.","journal-title":"Diabetologia"},{"issue":"1","key":"786_CR102","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1186\/s13287-022-02941-w","volume":"13","author":"M Izadi","year":"2022","unstructured":"Izadi M, Sadr Hashemi Nejad A, Moazenchi M, Masoumi S, Rabbani A, Kompani F, et\u00a0al. Mesenchymal stem cell transplantation in newly diagnosed type-1 diabetes patients: a phase I\/II randomized placebo-controlled clinical trial. Stem Cell Res Ther. 2022;13(1):264.","journal-title":"Stem Cell Res Ther."},{"key":"786_CR103","doi-asserted-by":"publisher","first-page":"993","DOI":"10.3389\/fimmu.2020.00993","volume":"11","author":"DB Araujo","year":"2020","unstructured":"Araujo DB, Dantas JR, Silva KR, Souto DL, Pereira MDFC, Moreira JP, et\u00a0al. Allogenic adipose tissue-derived stromal\/stem cells and vitamin D supplementation in patients with recent-onset type 1 diabetes mellitus: a 3-month follow-up pilot study. Front Immunol. 2020;11:993.","journal-title":"Front Immunol"},{"issue":"2","key":"786_CR104","doi-asserted-by":"publisher","first-page":"587","DOI":"10.2337\/db14-0656","volume":"64","author":"P-O Carlsson","year":"2014","unstructured":"Carlsson P-O, Schwarcz E, Korsgren O, Le Blanc K. Preserved \u03b2-cell function in type 1 diabetes by mesenchymal stromal cells. Diabetes. 2014;64(2):587\u201392.","journal-title":"Diabetes"},{"issue":"3","key":"786_CR105","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1507\/endocrj.EJ12-0343","volume":"60","author":"J Hu","year":"2013","unstructured":"Hu J, Yu X, Wang Z, Wang F, Wang L, Gao H, et\u00a0al. Long term effects of the implantation of Wharton\u2019s jelly-derived mesenchymal stem cells from the umbilical cord for newly-onset type 1 diabetes mellitus. Endocr J. 2013;60(3):347\u201357.","journal-title":"Endocr J"},{"issue":"2","key":"786_CR106","doi-asserted-by":"publisher","first-page":"530","DOI":"10.1073\/pnas.1423008112","volume":"112","author":"Q Zhao","year":"2015","unstructured":"Zhao Q, Gregory CA, Lee RH, Reger RL, Qin L, Hai B, et\u00a0al. MSCs derived from iPSCs with a modified protocol are tumor-tropic but have much less potential to promote tumors than bone marrow MSCs. Proc Natl Acad Sci. 2015;112(2):530\u20135.","journal-title":"Proc Natl Acad Sci"},{"issue":"1","key":"786_CR107","doi-asserted-by":"publisher","DOI":"10.1016\/j.tranon.2020.100948","volume":"14","author":"C Li","year":"2021","unstructured":"Li C, Zhao H, Wang B. Mesenchymal stem\/stromal cells: developmental origin, tumorigenesis and translational cancer therapeutics. Transl Oncol. 2021;14(1): 100948.","journal-title":"Transl Oncol"},{"key":"786_CR108","doi-asserted-by":"publisher","first-page":"1047907","DOI":"10.3389\/fonc.2022.1047907","volume":"12","author":"L Zhang","year":"2022","unstructured":"Zhang L, Xiang J, Zhang F, Liu L, Hu C. MSCs can be a double-edged sword in tumorigenesis. Front Oncol. 2022;12:1047907.","journal-title":"Front Oncol"},{"issue":"49","key":"786_CR109","doi-asserted-by":"publisher","first-page":"3545","DOI":"10.1038\/s41388-024-03183-1","volume":"43","author":"R Antoon","year":"2024","unstructured":"Antoon R, Overdevest N, Saleh AH, Keating A. Mesenchymal stromal cells as cancer promoters. Oncogene. 2024;43(49):3545\u201355.","journal-title":"Oncogene"},{"issue":"7","key":"786_CR110","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1016\/j.jcyt.2013.03.005","volume":"15","author":"L Barkholt","year":"2013","unstructured":"Barkholt L, Flory E, Jekerle V, Lucas-Samuel S, Ahnert P, Bisset L, et\u00a0al. Risk of tumorigenicity in mesenchymal stromal cell\u2013based therapies\u2014Bridging scientific observations and regulatory viewpoints. Cytotherapy. 2013;15(7):753\u20139.","journal-title":"Cytotherapy"},{"key":"786_CR111","doi-asserted-by":"crossref","unstructured":"Barra JM, Robino RA, Castro-Gutierrez R, Proia J, Russ HA, Ferreira LMR. Combinatorial genetic engineering strategy for immune protection of stem cell-derived beta cells by chimeric antigen receptor regulatory T cells. Cell Reports. 2024;43(11).","DOI":"10.1016\/j.celrep.2024.114994"},{"issue":"6","key":"786_CR112","doi-asserted-by":"publisher","first-page":"806","DOI":"10.1007\/s12015-013-9457-0","volume":"9","author":"P Lu","year":"2013","unstructured":"Lu P, Chen J, He L, Ren J, Chen H, Rao L, et\u00a0al. Generating hypoimmunogenic human embryonic stem cells by the disruption of beta 2-microglobulin. Stem Cell Rev Rep. 2013;9(6):806\u201313.","journal-title":"Stem Cell Rev Rep"},{"issue":"6","key":"786_CR113","doi-asserted-by":"publisher","first-page":"1232","DOI":"10.1038\/mt.2013.59","volume":"21","author":"L Riolobos","year":"2013","unstructured":"Riolobos L, Hirata RK, Turtle CJ, Wang PR, Gornalusse GG, Zavajlevski M, et\u00a0al. HLA engineering of human pluripotent stem cells. Mol Ther. 2013;21(6):1232\u201341.","journal-title":"Mol Ther"},{"issue":"4","key":"786_CR114","doi-asserted-by":"publisher","first-page":"566","DOI":"10.1016\/j.stem.2019.02.005","volume":"24","author":"H Xu","year":"2019","unstructured":"Xu H, Wang B, Ono M, Kagita A, Fujii K, Sasakawa N, et\u00a0al. Targeted disruption of HLA genes via CRISPR-Cas9 generates iPSCs with enhanced immune compatibility. Cell Stem Cell. 2019;24(4):566-78 e7.","journal-title":"Cell Stem Cell"},{"issue":"21","key":"786_CR115","doi-asserted-by":"publisher","first-page":"10441","DOI":"10.1073\/pnas.1902566116","volume":"116","author":"X Han","year":"2019","unstructured":"Han X, Wang M, Duan S, Franco PJ, Kenty JH, Hedrick P, et\u00a0al. Generation of hypoimmunogenic human pluripotent stem cells. Proc Natl Acad Sci U S A. 2019;116(21):10441\u20136.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"11","key":"786_CR116","doi-asserted-by":"publisher","first-page":"1423","DOI":"10.1002\/stem.3269","volume":"38","author":"L Shi","year":"2020","unstructured":"Shi L, Li W, Liu Y, Chen Z, Hui Y, Hao P, et\u00a0al. Generation of hypoimmunogenic human pluripotent stem cells via expression of membrane-bound and secreted beta2m-HLA-G fusion proteins. Stem Cells. 2020;38(11):1423\u201337.","journal-title":"Stem Cells"},{"issue":"1","key":"786_CR117","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/s13287-023-03308-5","volume":"14","author":"ME Bogomiakova","year":"2023","unstructured":"Bogomiakova ME, Sekretova EK, Anufrieva KS, Khabarova PO, Kazakova AN, Bobrovsky PA, et\u00a0al. iPSC-derived cells lack immune tolerance to autologous NK-cells due to imbalance in ligands for activating and inhibitory NK-cell receptors. Stem Cell Res Ther. 2023;14(1):77.","journal-title":"Stem Cell Res Ther"},{"issue":"3","key":"786_CR118","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1038\/s12276-025-01422-3","volume":"57","author":"J Kim","year":"2025","unstructured":"Kim J, Nam Y, Jeon D, Choi Y, Choi S, Hong CP, et\u00a0al. Generation of hypoimmunogenic universal iPS cells through HLA-type gene knockout. Exp Mol Med. 2025;57(3):686\u201399.","journal-title":"Exp Mol Med"},{"issue":"21","key":"786_CR119","doi-asserted-by":"publisher","first-page":"11520","DOI":"10.1073\/pnas.94.21.11520","volume":"94","author":"N Rouas-Freiss","year":"1997","unstructured":"Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A. 1997;94(21):11520\u20135.","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"2","key":"786_CR120","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1016\/j.scr.2014.08.004","volume":"13","author":"L Zhao","year":"2014","unstructured":"Zhao L, Teklemariam T, Hantash BM. Heterelogous expression of mutated HLA-G decreases immunogenicity of human embryonic stem cells and their epidermal derivatives. Stem Cell Res. 2014;13(2):342\u201354.","journal-title":"Stem Cell Res"},{"key":"786_CR121","volume-title":"The impact of food bioactives on health: in\u00a0vitro and ex vivo models [Internet]","author":"CR Kleiveland","year":"2015","unstructured":"Kleiveland CR, et\u00a0al. Chapter 15: Peripheral blood mononuclear cells. In: Verhoeckx KCP, L\u00f3pez-Exp\u00f3sito I, et\u00a0al., editors. The impact of food bioactives on health: in\u00a0vitro and ex vivo models [Internet]. Cham (CH): Springer; 2015."},{"issue":"3","key":"786_CR122","doi-asserted-by":"publisher","first-page":"413","DOI":"10.1038\/s41587-023-01784-x","volume":"42","author":"X Hu","year":"2024","unstructured":"Hu X, White K, Olroyd AG, DeJesus R, Dominguez AA, Dowdle WE, et\u00a0al. Hypoimmune induced pluripotent stem cells survive long term in fully immunocompetent, allogeneic rhesus macaques. Nat Biotechnol. 2024;42(3):413\u201323.","journal-title":"Nat Biotechnol"},{"issue":"7","key":"786_CR123","doi-asserted-by":"publisher","first-page":"3513","DOI":"10.4049\/jimmunol.1401323","volume":"194","author":"I Katano","year":"2015","unstructured":"Katano I, Takahashi T, Ito R, Kamisako T, Mizusawa T, Ka Y, et\u00a0al. Predominant development of mature and functional human NK cells in a novel human IL-2-producing transgenic NOG mouse. J Immunol. 2015;194(7):3513\u201325.","journal-title":"J Immunol"},{"key":"786_CR124","doi-asserted-by":"publisher","first-page":"643852","DOI":"10.3389\/fimmu.2021.643852","volume":"12","author":"T Martinov","year":"2021","unstructured":"Martinov T, McKenna KM, Tan WH, Collins EJ, Kehret AR, Linton JD, et\u00a0al. Building the next generation of humanized hemato-lymphoid system mice. Front Immunol. 2021;12:643852.","journal-title":"Front Immunol"},{"key":"786_CR125","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1146\/annurev-animal-020420-033029","volume":"10","author":"W Ye","year":"2022","unstructured":"Ye W, Chen Q. Potential applications and perspectives of humanized mouse models. Ann Rev Anim Biosci. 2022;10:395\u2013417.","journal-title":"Ann Rev Anim Biosci."},{"issue":"1","key":"786_CR126","doi-asserted-by":"publisher","first-page":"121","DOI":"10.1016\/j.stem.2013.11.014","volume":"14","author":"Z Rong","year":"2014","unstructured":"Rong Z, Wang M, Hu Z, Stradner M, Zhu S, Kong H, et\u00a0al. An effective approach to prevent immune rejection of human ESC-derived allografts. Cell Stem Cell. 2014;14(1):121\u201330.","journal-title":"Cell Stem Cell"},{"issue":"4","key":"786_CR127","doi-asserted-by":"publisher","first-page":"427","DOI":"10.1038\/s41551-023-01133-y","volume":"8","author":"J Harding","year":"2024","unstructured":"Harding J, Vintersten-Nagy K, Yang H, Tang JK, Shutova M, Jong ED, et\u00a0al. Immune-privileged tissues formed from immunologically cloaked mouse embryonic stem cells survive long term in allogeneic hosts. Nat Biomed Eng. 2024;8(4):427\u201342.","journal-title":"Nat Biomed Eng"},{"key":"786_CR128","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1016\/j.omtm.2022.05.010","volume":"26","author":"Y Kitano","year":"2022","unstructured":"Kitano Y, Nishimura S, Kato TM, Ueda A, Takigawa K, Umekage M, et\u00a0al. Generation of hypoimmunogenic induced pluripotent stem cells by CRISPR-Cas9 system and detailed evaluation for clinical application. Mol Ther Methods Clin Dev. 2022;26:15\u201325.","journal-title":"Mol Ther Methods Clin Dev"},{"key":"786_CR129","doi-asserted-by":"crossref","unstructured":"Silver SE, Howells AR, Arhontoulis DC, Randolph LN, Hyams NA, Barrs RW, et\u00a0al. Hypoimmunogenic hPSC-derived cardiac organoids for immune evasion and heart repair. bioRxiv. 2025:2025.04.09.648007.","DOI":"10.1101\/2025.04.09.648007"},{"issue":"4","key":"786_CR130","doi-asserted-by":"publisher","first-page":"940","DOI":"10.1097\/00007890-199304000-00046","volume":"55","author":"X Li","year":"1993","unstructured":"Li X, Faustman D. Use of donor beta 2-microglobulin-deficient transgenic mouse liver cells for isografts, allografts, and xenografts. Transplantation. 1993;55(4):940\u20136.","journal-title":"Transplantation"},{"issue":"5","key":"786_CR131","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.stem.2014.10.004","volume":"15","author":"PK Mandal","year":"2014","unstructured":"Mandal PK, Ferreira LM, Collins R, Meissner TB, Boutwell CL, Friesen M, et\u00a0al. Efficient ablation of genes in human hematopoietic stem and effector cells using CRISPR\/Cas9. Cell Stem Cell. 2014;15(5):643\u201352.","journal-title":"Cell Stem Cell"},{"issue":"8","key":"786_CR132","doi-asserted-by":"publisher","first-page":"765","DOI":"10.1038\/nbt.3860","volume":"35","author":"GG Gornalusse","year":"2017","unstructured":"Gornalusse GG, Hirata RK, Funk SE, Riolobos L, Lopes VS, Manske G, et\u00a0al. HLA-E-expressing pluripotent stem cells escape allogeneic responses and lysis by NK cells. Nat Biotechnol. 2017;35(8):765\u201372.","journal-title":"Nat Biotechnol"},{"issue":"1","key":"786_CR133","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2022.100879","volume":"4","author":"D Gerace","year":"2023","unstructured":"Gerace D, Zhou Q, Kenty JH, Veres A, Sintov E, Wang X, et\u00a0al. Engineering human stem cell-derived islets to evade immune rejection and promote localized immune tolerance. Cell Rep Med. 2023;4(1): 100879.","journal-title":"Cell Rep Med"},{"issue":"8","key":"786_CR134","doi-asserted-by":"publisher","first-page":"1341","DOI":"10.1182\/blood-2013-03-478255","volume":"122","author":"H Torikai","year":"2013","unstructured":"Torikai H, Reik A, Soldner F, Warren EH, Yuen C, Zhou Y, et\u00a0al. Toward eliminating HLA class I expression to generate universal cells from allogeneic donors. Blood. 2013;122(8):1341\u20139.","journal-title":"Blood"},{"issue":"11 Suppl","key":"786_CR135","first-page":"S3","volume":"124","author":"T Deuse","year":"2011","unstructured":"Deuse T, Seifert M, Phillips N, Fire A, Tyan D, Kay M, et\u00a0al. Human leukocyte antigen I knockdown human embryonic stem cells induce host ignorance and achieve prolonged xenogeneic survival. Circulation. 2011;124(11 Suppl):S3-9.","journal-title":"Circulation"},{"issue":"2","key":"786_CR136","doi-asserted-by":"publisher","first-page":"381","DOI":"10.4049\/jimmunol.152.2.381","volume":"152","author":"I Bacik","year":"1994","unstructured":"Bacik I, Cox JH, Anderson R, Yewdell JW, Bennink JR. TAP (transporter associated with antigen processing)-independent presentation of endogenously synthesized peptides is enhanced by endoplasmic reticulum insertion sequences located at the amino- but not carboxyl-terminus of the peptide. J Immunol. 1994;152(2):381\u20137.","journal-title":"J Immunol"},{"key":"786_CR137","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/s40659-015-0051-6","volume":"48","author":"H Chen","year":"2015","unstructured":"Chen H, Li Y, Lin X, Cui D, Cui C, Li H, et\u00a0al. Functional disruption of human leukocyte antigen II in human embryonic stem cell. Biol Res. 2015;48:59.","journal-title":"Biol Res"},{"issue":"23","key":"786_CR138","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.118.010239","volume":"7","author":"S Mattapally","year":"2018","unstructured":"Mattapally S, Pawlik KM, Fast VG, Zumaquero E, Lund FE, Randall TD, et\u00a0al. Human leukocyte antigen class I and II knockout human induced pluripotent stem cell-derived cells: universal donor for cell therapy. J Am Heart Assoc. 2018;7(23): e010239.","journal-title":"J Am Heart Assoc"},{"issue":"2","key":"786_CR139","doi-asserted-by":"publisher","first-page":"471","DOI":"10.1002\/eji.200324195","volume":"34","author":"CV Arancibia-C\u00e1rcamo","year":"2004","unstructured":"Arancibia-C\u00e1rcamo CV, Osawa H, Arnett HA, H\u00e1skova Z, George AJT, Ono SJ, et\u00a0al. A CIITA-independent pathway that promotes expression of endogenous rather than exogenous peptides in immune-privileged sites. Eur J Immunol. 2004;34(2):471\u201380.","journal-title":"Eur J Immunol"},{"issue":"10","key":"786_CR140","doi-asserted-by":"publisher","first-page":"4741","DOI":"10.4049\/jimmunol.158.10.4741","volume":"158","author":"H Zhou","year":"1997","unstructured":"Zhou H, Su HS, Zhang X, Douhan J 3rd, Glimcher LH. CIITA-dependent and -independent class II MHC expression revealed by a dominant negative mutant. J Immunol. 1997;158(10):4741\u20139.","journal-title":"J Immunol"},{"issue":"40","key":"786_CR141","doi-asserted-by":"publisher","first-page":"12750","DOI":"10.1021\/bi030262o","volume":"43","author":"AL Burd","year":"2004","unstructured":"Burd AL, Ingraham RH, Goldrick SE, Kroe RR, Crute JJ, Grygon CA. Assembly of major histocompatibility complex (MHC) class II transcription factors: association and promoter recognition of RFX proteins. Biochemistry. 2004;43(40):12750\u201360.","journal-title":"Biochemistry"},{"issue":"11","key":"786_CR142","doi-asserted-by":"publisher","first-page":"1102","DOI":"10.1016\/S0198-8859(00)00198-1","volume":"61","author":"SJ Gobin","year":"2000","unstructured":"Gobin SJ, van den Elsen PJ. Transcriptional regulation of the MHC class Ib genes HLA-E, HLA-F, and HLA-G. Hum Immunol. 2000;61(11):1102\u20137.","journal-title":"Hum Immunol"},{"key":"786_CR143","doi-asserted-by":"publisher","first-page":"8873383","DOI":"10.1155\/2021\/8873383","volume":"2021","author":"YW Kwon","year":"2021","unstructured":"Kwon YW, Ahn HS, Lee JW, Yang HM, Cho HJ, Kim SJ, et\u00a0al. HLA DR genome editing with TALENs in human iPSCs produced immune-tolerant dendritic cells. Stem Cells Int. 2021;2021:8873383.","journal-title":"Stem Cells Int"},{"issue":"1","key":"786_CR144","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1186\/s13287-024-03810-4","volume":"15","author":"N Tsuneyoshi","year":"2024","unstructured":"Tsuneyoshi N, Hosoya T, Takeno Y, Saitoh K, Murai H, Amimoto N, et\u00a0al. Hypoimmunogenic human iPSCs expressing HLA-G, PD-L1, and PD-L2 evade innate and adaptive immunity. Stem Cell Res Ther. 2024;15(1):193.","journal-title":"Stem Cell Res Ther"},{"key":"786_CR145","first-page":"33","volume-title":"Advances in Immunology","author":"ED Carosella","year":"2015","unstructured":"Carosella ED, Rouas-Freiss N, Roux DT-L, Moreau P, LeMaoult J. Chapter two\u2014HLA-G: an immune checkpoint molecule. In: Alt FW, editor. Advances in Immunology, vol. 127. Academic Press; 2015. p. 33\u2013144."},{"issue":"3","key":"786_CR146","doi-asserted-by":"publisher","first-page":"e20200839","DOI":"10.1084\/jem.20200839","volume":"218","author":"T Deuse","year":"2021","unstructured":"Deuse T, Hu X, Agbor-Enoh S, Jang MK, Alawi M, Saygi C, Gravina A, Tediashvili G, Nguyen VQ, Liu Y, Valantine H, Lanier LL, Schrepfer S. The SIRP\u03b1-CD47 immune checkpoint in NK cells. J Exp Med. 2021;218(3):e20200839. https:\/\/doi.org\/10.1084\/jem.20200839.","journal-title":"J Exp Med"},{"issue":"1","key":"786_CR147","doi-asserted-by":"publisher","first-page":"49","DOI":"10.1016\/j.stemcr.2019.11.011","volume":"14","author":"D Suzuki","year":"2020","unstructured":"Suzuki D, Flahou C, Yoshikawa N, Stirblyte I, Hayashi Y, Sawaguchi A, et\u00a0al. iPSC-derived platelets depleted of HLA class I are inert to anti-HLA class I and natural killer cell immunity. Stem Cell Reports. 2020;14(1):49\u201359.","journal-title":"Stem Cell Reports"},{"issue":"5473","key":"786_CR148","doi-asserted-by":"publisher","first-page":"2051","DOI":"10.1126\/science.288.5473.2051","volume":"288","author":"P-A Oldenborg","year":"2000","unstructured":"Oldenborg P-A, Zheleznyak A, Fang Y-F, Lagenaur CF, Gresham HD, Lindberg FP. Role of CD47 as a marker of self on red blood cells. Science. 2000;288(5473):2051\u20134.","journal-title":"Science"},{"issue":"9","key":"786_CR149","doi-asserted-by":"publisher","first-page":"2147","DOI":"10.1517\/13543784.9.9.2147","volume":"9","author":"N Najafian","year":"2000","unstructured":"Najafian N, Sayegh MH. CTLA4-Ig: a novel immunosuppressive agent. Expert Opin Investig Drugs. 2000;9(9):2147\u201357.","journal-title":"Expert Opin Investig Drugs"},{"key":"786_CR150","doi-asserted-by":"publisher","first-page":"677","DOI":"10.1146\/annurev.immunol.26.021607.090331","volume":"26","author":"ME Keir","year":"2008","unstructured":"Keir ME, Butte MJ, Freeman GJ, Sharpe AH. PD-1 and its ligands in tolerance and immunity. Annu Rev Immunol. 2008;26:677\u2013704.","journal-title":"Annu Rev Immunol"},{"issue":"6","key":"786_CR151","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3727\/096368908786092694","volume":"17","author":"YH Kim","year":"2008","unstructured":"Kim YH, Lim DG, Wee YM, Kim JH, Yun CO, Choi MY, et\u00a0al. Viral IL-10 gene transfer prolongs rat islet\u00a0allograft survival. Cell Transplant. 2008;17(6):609\u201318.","journal-title":"Cell Transplant"},{"issue":"8","key":"786_CR152","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1038\/nm.3267","volume":"19","author":"AS Lee","year":"2013","unstructured":"Lee AS, Tang C, Rao MS, Weissman IL, Wu JC. Tumorigenicity as a clinical hurdle for pluripotent stem cell therapies. Nat Med. 2013;19(8):998\u20131004.","journal-title":"Nat Med"},{"issue":"1","key":"786_CR153","doi-asserted-by":"publisher","first-page":"34","DOI":"10.4161\/org.24317","volume":"9","author":"W Li","year":"2013","unstructured":"Li W, Xiang AP. Safeguarding clinical translation of pluripotent stem cells with suicide genes. Organogenesis. 2013;9(1):34\u20139.","journal-title":"Organogenesis"},{"issue":"7733","key":"786_CR154","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1038\/s41586-018-0733-7","volume":"563","author":"Q Liang","year":"2018","unstructured":"Liang Q, Monetti C, Shutova MV, Neely EJ, Hacibekiroglu S, Yang H, et\u00a0al. Linking a cell-division gene and a suicide gene to define and improve cell therapy safety. Nature. 2018;563(7733):701\u20134.","journal-title":"Nature"},{"issue":"3","key":"786_CR155","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1016\/j.stemcr.2017.02.003","volume":"8","author":"G Itakura","year":"2017","unstructured":"Itakura G, Kawabata S, Ando M, Nishiyama Y, Sugai K, Ozaki M, et\u00a0al. Fail-safe system against potential tumorigenicity after transplantation of iPSC derivatives. Stem Cell Rep. 2017;8(3):673\u201384.","journal-title":"Stem Cell Rep"},{"issue":"10","key":"786_CR156","doi-asserted-by":"publisher","first-page":"1782","DOI":"10.1002\/stem.500","volume":"28","author":"TL Chung","year":"2010","unstructured":"Chung TL, Turner JP, Thaker NY, Kolle G, Cooper-White JJ, Grimmond SM, et\u00a0al. Ascorbate promotes epigenetic activation of CD30 in human embryonic stem cells. Stem Cells. 2010;28(10):1782\u201393.","journal-title":"Stem Cells"},{"issue":"8","key":"786_CR157","doi-asserted-by":"publisher","first-page":"665","DOI":"10.1002\/gcc.20574","volume":"47","author":"S Yang","year":"2008","unstructured":"Yang S, Lin G, Tan Y-Q, Zhou D, Deng L-Y, Cheng D-H, et\u00a0al. Tumor progression of culture-adapted human embryonic stem cells during long-term culture. Genes Chromosom Cancer. 2008;47(8):665\u201379.","journal-title":"Genes Chromosom Cancer"},{"issue":"7653","key":"786_CR158","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1038\/nature22312","volume":"545","author":"FT Merkle","year":"2017","unstructured":"Merkle FT, Ghosh S, Kamitaki N, Mitchell J, Avior Y, Mello C, et\u00a0al. Human pluripotent stem cells recurrently acquire and expand dominant negative P53 mutations. Nature. 2017;545(7653):229\u201333.","journal-title":"Nature"},{"issue":"9","key":"786_CR159","doi-asserted-by":"publisher","first-page":"2269","DOI":"10.1002\/stem.2407","volume":"34","author":"D Zheng","year":"2016","unstructured":"Zheng D, Wang X, Xu RH. Concise review: one stone for multiple birds: generating universally compatible human embryonic stem cells. Stem Cells. 2016;34(9):2269\u201375.","journal-title":"Stem Cells"},{"issue":"3","key":"786_CR160","doi-asserted-by":"publisher","first-page":"611","DOI":"10.1016\/j.stemcr.2019.01.012","volume":"12","author":"MMF Qadir","year":"2019","unstructured":"Qadir MMF, \u00c1lvarez-Cubela S, Belle K, Sapir T, Messaggio F, Johnson KB, et\u00a0al. A double fail-safe approach to prevent tumorigenesis and select pancreatic \u03b2 cells from human embryonic stem cells. Stem Cell Reports. 2019;12(3):611\u201323.","journal-title":"Stem Cell Reports"},{"issue":"1","key":"786_CR161","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1038\/mt.2011.273","volume":"20","author":"RA Morgan","year":"2012","unstructured":"Morgan RA. Live and let die: a new suicide gene therapy moves to the clinic. Mol Ther. 2012;20(1):11\u20133.","journal-title":"Mol Ther"},{"issue":"4","key":"786_CR162","doi-asserted-by":"publisher","first-page":"619","DOI":"10.1089\/scd.2007.0235","volume":"17","author":"A Hara","year":"2008","unstructured":"Hara A, Aoki H, Taguchi A, Niwa M, Yamada Y, Kunisada T, et\u00a0al. Neuron-like differentiation and selective ablation of undifferentiated embryonic stem cells containing suicide gene with Oct-4 promoter. Stem Cells Dev. 2008;17(4):619\u201327.","journal-title":"Stem Cells Dev"},{"issue":"3","key":"786_CR163","doi-asserted-by":"publisher","first-page":"257","DOI":"10.1634\/stemcells.21-3-257","volume":"21","author":"M Schuldiner","year":"2003","unstructured":"Schuldiner M, Itskovitz-Eldor J, Benvenisty N. Selective ablation of human embryonic stem cells expressing a \u201csuicide\u201d gene. Stem Cells. 2003;21(3):257\u201365.","journal-title":"Stem Cells"},{"issue":"14","key":"786_CR164","doi-asserted-by":"publisher","first-page":"955","DOI":"10.1038\/sj.gt.3301771","volume":"9","author":"MU Fareed","year":"2002","unstructured":"Fareed MU, Moolten FL. Suicide gene transduction sensitizes murine embryonic and human mesenchymal stem cells to ablation on demand \u2013 A fail-safe protection against cellular misbehavior. Gene Ther. 2002;9(14):955\u201362.","journal-title":"Gene Ther"},{"issue":"15","key":"786_CR165","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1093\/jnci\/91.15.1321","volume":"91","author":"J Albanell","year":"1999","unstructured":"Albanell J, Bosl GJ, Reuter VE, Engelhardt M, Franco S, Moore MAS, et\u00a0al. Telomerase activity in germ cell cancers and mature teratomas. JNCI J Natl Cancer Inst. 1999;91(15):1321\u20136.","journal-title":"JNCI J Natl Cancer Inst"},{"issue":"1","key":"786_CR166","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1016\/j.tibtech.2006.10.010","volume":"25","author":"H Hentze","year":"2007","unstructured":"Hentze H, Graichen R, Colman A. Cell therapy and the safety of embryonic stem cell-derived grafts. Trends Biotechnol. 2007;25(1):24\u201332.","journal-title":"Trends Biotechnol"},{"issue":"4","key":"786_CR167","doi-asserted-by":"publisher","first-page":"346","DOI":"10.1016\/j.cels.2016.08.011","volume":"3","author":"M Baron","year":"2016","unstructured":"Baron M, Veres A, Wolock SL, Faust AL, Gaujoux R, Vetere A, et\u00a0al. A single-cell transcriptomic map of the human and mouse pancreas reveals inter- and intra-cell population structure. Cell Syst. 2016;3(4):346-60.e4.","journal-title":"Cell Syst"},{"issue":"6","key":"786_CR168","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1634\/stemcells.2007-0576","volume":"26","author":"AB Choo","year":"2008","unstructured":"Choo AB, Tan HL, Ang SN, Fong WJ, Chin A, Lo J, et\u00a0al. Selection against undifferentiated human embryonic stem cells by a cytotoxic antibody recognizing podocalyxin-like protein-1. Stem Cells. 2008;26(6):1454\u201363.","journal-title":"Stem Cells"},{"issue":"8","key":"786_CR169","doi-asserted-by":"publisher","first-page":"1792","DOI":"10.1002\/stem.109","volume":"27","author":"HL Tan","year":"2009","unstructured":"Tan HL, Fong WJ, Lee EH, Yap M, Choo A. mAb 84, a cytotoxic antibody that kills undifferentiated human embryonic stem cells via oncosis. Stem Cells. 2009;27(8):1792\u2013801.","journal-title":"Stem Cells"},{"issue":"9\u201310","key":"786_CR170","first-page":"899","volume":"18","author":"K Schriebl","year":"2011","unstructured":"Schriebl K, Satianegara G, Hwang A, Tan HL, Fong WJ, Yang HH, et\u00a0al. Selective removal of undifferentiated human embryonic stem cells using magnetic activated cell sorting followed by a cytotoxic antibody. Tissue Eng Part A. 2011;18(9\u201310):899\u2013909.","journal-title":"Tissue Eng Part A"},{"key":"786_CR171","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2022.867015","volume":"13","author":"ZB Bjornson-Hooper","year":"2022","unstructured":"Bjornson-Hooper ZB, Fragiadakis GK, Spitzer MH, Chen H, Madhireddy D, Hu K, et\u00a0al. A comprehensive atlas of immunological differences between humans, mice, and non-human primates. Front Immunol. 2022;13: 867015.","journal-title":"Front Immunol"},{"issue":"6","key":"786_CR172","doi-asserted-by":"publisher","first-page":"486","DOI":"10.1007\/BF00461694","volume":"9","author":"CB Kemp","year":"1973","unstructured":"Kemp CB, Knight MJ, Scharp DW, Ballinger WF, Lacy PE. Effect of transplantation site on the results of pancreatic islet isografts in diabetic rats. Diabetologia. 1973;9(6):486\u201391.","journal-title":"Diabetologia"},{"issue":"10","key":"786_CR173","doi-asserted-by":"publisher","first-page":"1961","DOI":"10.1007\/s00125-017-4362-8","volume":"60","author":"RA Stokes","year":"2017","unstructured":"Stokes RA, Cheng K, Lalwani A, Swarbrick MM, Thomas HE, Loudovaris T, et\u00a0al. Transplantation sites for human and murine islets. Diabetologia. 2017;60(10):1961\u201371.","journal-title":"Diabetologia"},{"issue":"10","key":"786_CR174","doi-asserted-by":"publisher","first-page":"1972","DOI":"10.1007\/s00125-017-4363-7","volume":"60","author":"RA Stokes","year":"2017","unstructured":"Stokes RA, Simond DM, Burns H, Patel AT, O\u2019Connell PJ, Gunton JE, et\u00a0al. Transplantation sites for porcine islets. Diabetologia. 2017;60(10):1972\u20136.","journal-title":"Diabetologia"},{"issue":"2","key":"786_CR175","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3346\/jkms.2010.25.2.203","volume":"25","author":"HI Kim","year":"2010","unstructured":"Kim HI, Yu JE, Park CG, Kim SJ. Comparison of four pancreatic islet implantation sites. J Korean Med Sci. 2010;25(2):203\u201310.","journal-title":"J Korean Med Sci"},{"key":"786_CR176","doi-asserted-by":"publisher","first-page":"732431","DOI":"10.3389\/fendo.2021.732431","volume":"12","author":"F Cayabyab","year":"2021","unstructured":"Cayabyab F, Nih LR, Yoshihara E. Advances in pancreatic islet transplantation sites for the treatment of diabetes. Front Endocrinol. 2021;12:732431.","journal-title":"Front Endocrinol"},{"issue":"9","key":"786_CR177","doi-asserted-by":"publisher","first-page":"1161","DOI":"10.2337\/diab.45.9.1161","volume":"45","author":"AM Davalli","year":"1996","unstructured":"Davalli AM, Scaglia L, Zangen DH, Hollister J, Bonner-Weir S, Weir GC. Vulnerability of islets in the immediate posttransplantation period. Dynamic changes in structure and function. Diabetes. 1996;45(9):1161\u20137.","journal-title":"Diabetes"},{"issue":"6","key":"786_CR178","doi-asserted-by":"publisher","first-page":"817","DOI":"10.1097\/00007890-199503000-00003","volume":"59","author":"AM Davalli","year":"1995","unstructured":"Davalli AM, Ogawa Y, Ricordi C, Scharp DW, Bonner-Weir S, Weir GC. A selective decrease in the beta cell mass of human islets transplanted into diabetic nude mice. Transplantation. 1995;59(6):817\u201320.","journal-title":"Transplantation"},{"issue":"3","key":"786_CR179","doi-asserted-by":"publisher","first-page":"807","DOI":"10.1016\/j.stemcr.2017.07.012","volume":"9","author":"G Faleo","year":"2017","unstructured":"Faleo G, Russ HA, Wisel S, Parent AV, Nguyen V, Nair GG, et\u00a0al. Mitigating ischemic injury of stem cell-derived insulin-producing cells after transplant. Stem Cell Rep. 2017;9(3):807\u201319.","journal-title":"Stem Cell Rep"},{"issue":"52","key":"786_CR180","doi-asserted-by":"publisher","first-page":"21456","DOI":"10.1073\/pnas.1211659110","volume":"109","author":"R Rodriguez-Diaz","year":"2012","unstructured":"Rodriguez-Diaz R, Speier S, Molano RD, Formoso A, Gans I, Abdulreda MH, et\u00a0al. Noninvasive in\u00a0vivo model demonstrating the effects of autonomic innervation on pancreatic islet function. Proc Natl Acad Sci. 2012;109(52):21456\u201361.","journal-title":"Proc Natl Acad Sci"},{"issue":"2","key":"786_CR181","doi-asserted-by":"publisher","first-page":"e51","DOI":"10.1097\/00006676-200408000-00019","volume":"29","author":"T Kiba","year":"2004","unstructured":"Kiba T. Relationships between the autonomic nervous system and the pancreas including regulation of regeneration and apoptosis: recent developments. Pancreas. 2004;29(2):e51\u20138.","journal-title":"Pancreas"},{"issue":"11","key":"786_CR182","doi-asserted-by":"publisher","first-page":"879","DOI":"10.1038\/nri1224","volume":"3","author":"JW Streilein","year":"2003","unstructured":"Streilein JW. Ocular immune privilege: therapeutic opportunities from an experiment of nature. Nat Rev Immunol. 2003;3(11):879\u201389.","journal-title":"Nat Rev Immunol"},{"issue":"6","key":"786_CR183","doi-asserted-by":"publisher","first-page":"1688","DOI":"10.1172\/JCI109631","volume":"64","author":"J Brown","year":"1979","unstructured":"Brown J, Mullen Y, Clark WR, Molnar IG, Heininger D. Importance of hepatic portal circulation for insulin action in streptozotocin-diabetic rats transplanted with fetal pancreases. J Clin Invest. 1979;64(6):1688\u201394.","journal-title":"J Clin Invest"},{"key":"786_CR184","doi-asserted-by":"publisher","DOI":"10.1155\/2014\/451035","volume":"2014","author":"MA Kanak","year":"2014","unstructured":"Kanak MA, Takita M, Kunnathodi F, Lawrence MC, Levy MF, Naziruddin B. Inflammatory response in islet transplantation. Int J Endocrinol. 2014;2014: 451035.","journal-title":"Int J Endocrinol"},{"issue":"2","key":"786_CR185","doi-asserted-by":"publisher","first-page":"98","DOI":"10.21037\/atm-20-3519","volume":"9","author":"WY Chung","year":"2021","unstructured":"Chung WY, Pollard CA, Kumar R, Drogemuller CJ, Naziruddin B, Stover C, et\u00a0al. A comparison of the inflammatory response following autologous compared with allogenic islet cell transplantation. Ann Transl Med. 2021;9(2):98.","journal-title":"Ann Transl Med"},{"issue":"5","key":"786_CR186","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.2337\/db12-1553","volume":"62","author":"AM Smink","year":"2013","unstructured":"Smink AM, Faas MM, de Vos P. Toward engineering a novel transplantation site for human pancreatic islets. Diabetes. 2013;62(5):1357\u201364.","journal-title":"Diabetes"},{"issue":"5","key":"786_CR187","first-page":"364","volume":"11","author":"E Cantarelli","year":"2011","unstructured":"Cantarelli E, Piemonti L. Alternative transplantation sites for pancreatic islet grafts. Curr DiabRep. 2011;11(5):364\u201374.","journal-title":"Curr DiabRep"},{"issue":"5","key":"786_CR188","first-page":"628","volume":"8","author":"JI Stagner","year":"2007","unstructured":"Stagner JI, Rilo HL, White KK. The pancreas as an islet transplantation site. Confirmation in a syngeneic rodent and canine autotransplant model. Jop. 2007;8(5):628\u201336.","journal-title":"Jop."},{"issue":"6","key":"786_CR189","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1080\/19382014.2019.1651164","volume":"11","author":"L Kosinova","year":"2019","unstructured":"Kosinova L, Patikova A, Jirak D, Galisova A, Vojtiskova A, Saudek F, et\u00a0al. A novel model for in\u00a0vivo quantification of immediate liver perfusion impairment after pancreatic islet transplantation. Islets. 2019;11(6):129\u201340.","journal-title":"Islets"},{"issue":"3","key":"786_CR190","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00534-011-0441-2","volume":"19","author":"T Kawahara","year":"2012","unstructured":"Kawahara T, Kin T, Shapiro AM. A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation. J Hepatobiliary Pancreat Sci. 2012;19(3):281\u20138.","journal-title":"J Hepatobiliary Pancreat Sci"},{"issue":"8","key":"786_CR191","doi-asserted-by":"publisher","first-page":"844","DOI":"10.1097\/TP.0000000000000334","volume":"98","author":"Z Ren","year":"2014","unstructured":"Ren Z, Jiang J, Lu H, Chen X, He Y, Zhang H, et\u00a0al. Intestinal microbial variation may predict early acute rejection after liver transplantation in rats. Transplantation. 2014;98(8):844\u201352.","journal-title":"Transplantation"},{"issue":"12","key":"786_CR192","doi-asserted-by":"publisher","first-page":"1449","DOI":"10.1002\/bjs.6391","volume":"95","author":"S Merani","year":"2008","unstructured":"Merani S, Toso C, Emamaullee J, Shapiro AMJ. Optimal implantation site for pancreatic islet transplantation. Br J Surg. 2008;95(12):1449\u201361.","journal-title":"Br J Surg"},{"issue":"8","key":"786_CR193","doi-asserted-by":"publisher","first-page":"3479","DOI":"10.1016\/j.transproceed.2005.09.023","volume":"37","author":"JH Juang","year":"2005","unstructured":"Juang JH, Hsu BR, Kuo CH. Islet transplantation at subcutaneous and intramuscular sites. Transplant Proc. 2005;37(8):3479\u201381.","journal-title":"Transplant Proc"},{"issue":"10","key":"786_CR194","doi-asserted-by":"publisher","first-page":"3523","DOI":"10.2337\/db13-0465","volume":"62","author":"P Maffi","year":"2013","unstructured":"Maffi P, Balzano G, Ponzoni M, Nano R, Sordi V, Melzi R, et\u00a0al. Autologous pancreatic islet transplantation in human bone marrow. Diabetes. 2013;62(10):3523\u201331.","journal-title":"Diabetes"},{"key":"786_CR195","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1016\/j.reth.2018.04.002","volume":"8","author":"I Fujita","year":"2018","unstructured":"Fujita I, Utoh R, Yamamoto M, Okano T, Yamato M. The liver surface as a favorable site for islet cell sheet transplantation in type 1 diabetes model mice. Regen Ther. 2018;8:65\u201372.","journal-title":"Regen Ther"},{"issue":"1","key":"786_CR196","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1038\/s42255-022-00713-7","volume":"5","author":"Z Liang","year":"2023","unstructured":"Liang Z, Sun D, Lu S, Lei Z, Wang S, Luo Z, et\u00a0al. Implantation underneath the abdominal anterior rectus sheath enables effective and functional engraftment of stem-cell-derived islets. Nat Metab. 2023;5(1):29\u201340.","journal-title":"Nat Metab"},{"issue":"7","key":"786_CR197","doi-asserted-by":"publisher","DOI":"10.1097\/TXD.0000000000001658","volume":"10","author":"A Sun","year":"2024","unstructured":"Sun A, Hayat H, Kenyon E, Quadri T, Amos D, Perkins K, et\u00a0al. Brown adipose tissue as a unique niche for islet organoid transplantation: insights from in\u00a0vivo imaging. Transplant Direct. 2024;10(7): e1658.","journal-title":"Transplant Direct"},{"issue":"4","key":"786_CR198","doi-asserted-by":"publisher","first-page":"e152800","DOI":"10.1172\/jci.insight.152800","volume":"7","author":"JD Kepple","year":"2022","unstructured":"Kepple JD, Barra JM, Young ME, Hunter CS, Tse HM. Islet transplantation into brown adipose tissue can delay immune rejection. JCI Insight. 2022;7(4):e152800.","journal-title":"JCI Insight."},{"issue":"1","key":"786_CR199","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1002\/dmrr.2463","volume":"30","author":"N Sakata","year":"2014","unstructured":"Sakata N, Aoki T, Yoshimatsu G, Tsuchiya H, Hata T, Katayose Y, et\u00a0al. Strategy for clinical setting in intramuscular and subcutaneous islet transplantation. Diabetes Metab Res Rev. 2014;30(1):1\u201310.","journal-title":"Diabetes Metab Res Rev"},{"key":"786_CR200","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1016\/j.actbio.2019.05.051","volume":"95","author":"DT Bowers","year":"2019","unstructured":"Bowers DT, Song W, Wang LH, Ma M. Engineering the vasculature for islet transplantation. Acta Biomater. 2019;95:131\u201351.","journal-title":"Acta Biomater"},{"issue":"7","key":"786_CR201","doi-asserted-by":"publisher","first-page":"39","DOI":"10.1007\/s11892-018-1014-4","volume":"18","author":"AM Smink","year":"2018","unstructured":"Smink AM, de Vos P. Therapeutic strategies for modulating the extracellular matrix to improve pancreatic islet function and survival after transplantation. Curr Diab Rep. 2018;18(7):39.","journal-title":"Curr Diab Rep"},{"issue":"35","key":"786_CR202","doi-asserted-by":"publisher","first-page":"9337","DOI":"10.1073\/pnas.1619216114","volume":"114","author":"AE Vlahos","year":"2017","unstructured":"Vlahos AE, Cober N, Sefton MV. Modular tissue engineering for the vascularization of subcutaneously transplanted pancreatic islets. Proc Natl Acad Sci. 2017;114(35):9337\u201342.","journal-title":"Proc Natl Acad Sci"},{"issue":"9","key":"786_CR203","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1097\/TP.0b013e3181ba2e87","volume":"88","author":"P Witkowski","year":"2009","unstructured":"Witkowski P, Sondermeijer H, Hardy MA, Woodland DC, Lee K, Bhagat G, et\u00a0al. Islet grafting and imaging in a bioengineered intramuscular space. Transplantation. 2009;88(9):1065\u201374.","journal-title":"Transplantation"},{"issue":"1","key":"786_CR204","doi-asserted-by":"publisher","first-page":"9","DOI":"10.1038\/s41581-022-00636-2","volume":"19","author":"M Chavez","year":"2023","unstructured":"Chavez M, Chen X, Finn PB, Qi LS. Advances in CRISPR therapeutics. Nat Rev Nephrol. 2023;19(1):9\u201322.","journal-title":"Nat Rev Nephrol"},{"issue":"1","key":"786_CR205","first-page":"12","volume":"10","author":"Z-H Li","year":"2023","unstructured":"Li Z-H, Wang J, Xu J-P, Wang J, Yang X. Recent advances in CRISPR-based genome editing technology and its applications in cardiovascular research. Mil Med Res. 2023;10(1):12.","journal-title":"Mil Med Res"},{"key":"786_CR206","doi-asserted-by":"publisher","DOI":"10.1038\/mtna.2015.37","volume":"4","author":"X-H Zhang","year":"2015","unstructured":"Zhang X-H, Tee LY, Wang X-G, Huang Q-S, Yang S-H. Off-target effects in CRISPR\/Cas9-mediated genome engineering. Mol Ther Nucleic Acids. 2015;4: e264.","journal-title":"Mol Ther Nucleic Acids"},{"issue":"6S1","key":"786_CR207","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1097\/01.tp.0001122904.85848.1f","volume":"109","author":"G Siracusano","year":"2025","unstructured":"Siracusano G, Chimienti R, Tacconi C, Deambrogio F, Sordi V, Malnati M, et\u00a0al. Breaking immune evasion: NK cell surveillance of hypoimmunogenic IPSC-derived pancreatic islets during viral infections. Transplantation. 2025;109(6S1):8.","journal-title":"Transplantation"},{"issue":"5, Supplement","key":"786_CR208","doi-asserted-by":"publisher","first-page":"S47","DOI":"10.1016\/j.jcyt.2025.03.076","volume":"27","author":"JJ Novoa","year":"2025","unstructured":"Novoa JJ, Gaykema LH, Peerlings J, van Nieuwland RY, van der Slik AR, Goncalves MF, et\u00a0al. US2-mediated immune evasion: a novel strategy for generating hypoimmunogenic iPSC lines. Cytotherapy. 2025;27(5, Supplement):S47.","journal-title":"Cytotherapy"},{"issue":"9","key":"786_CR209","doi-asserted-by":"publisher","first-page":"1976","DOI":"10.1016\/j.stemcr.2022.08.002","volume":"17","author":"E Sintov","year":"2022","unstructured":"Sintov E, Nikolskiy I, Barrera V, Hyoje-Ryu Kenty J, Atkin AS, Gerace D, et\u00a0al. Whole-genome CRISPR screening identifies genetic manipulations to reduce immune rejection of stem cell-derived islets. Stem Cell Rep. 2022;17(9):1976\u201390.","journal-title":"Stem Cell Rep"}],"container-title":["Cellular & Molecular Biology Letters"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s11658-025-00786-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s11658-025-00786-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T14:04:06Z","timestamp":1759413846000},"score":1,"resource":{"primary":{"URL":"https:\/\/cmbl.biomedcentral.com\/articles\/10.1186\/s11658-025-00786-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10,2]]},"references-count":209,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12]]}},"alternative-id":["786"],"URL":"https:\/\/doi.org\/10.1186\/s11658-025-00786-8","relation":{},"ISSN":["1689-1392"],"issn-type":[{"value":"1689-1392","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,10,2]]},"assertion":[{"value":"24 April 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"11 August 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 October 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Not applicable.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"All other authors declare no conflicts of interest.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"112"}}